
Stephen E Litman MD
Geriatric Medicine, Hospice & Palliative Medicine
Principal Investigator Flourish Research Philadelphia
Join to view full profile
920 E Germantown PikeSuite 102Plymouth Meeting, PA 19462
Phone+1 610-277-8073
Fax+1 610-277-8046
Dr. Litman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Stephen Litman, MD, is an internal medicine specialist located in Plymouth Meeting, PA, with subspecialties in geriatric medicine and hospice and palliative medicine. He completed his residency at Abington Memorial Hospital and graduated from Universidad del Noreste in 1982. Since 2014, he has served as the Medical Director at Liberty Hospice. Dr. Litman has expertise in hospice and palliative care and geriatrics, particularly dementia. He has received several recognitions, including the CMS Meaningful Use Stage 1 Certification and recognition from the National Committee for Quality Assurance in the Physician Practice Connections and Patient-Centered Medical Home programs.
Education & Training
Abington Memorial HospitalResidency, Internal Medicine, 1983 - 1986
Universidad del NoresteClass of 1982
Certifications & Licensure
FL State Medical License 2003 - 2027
PA State Medical License 1984 - 2026
GA State Medical License 1984 - 1987
American Board of Internal Medicine Internal Medicine- Hospice Medical Director Certification BoardHMDC
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2013-2016
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2013-2016
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) Start of enrollment: 2025 Sep 02
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









